These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31761942)

  • 1. Insights From a Real-World Study of Molecular Test Performance for Indeterminate Thyroid Nodules.
    Angell TE
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31761942
    [No Abstract]   [Full Text] [Related]  

  • 2. Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.
    Endo M; Nabhan F; Porter K; Roll K; Shirley LA; Azaryan I; Tonkovich D; Perlick J; Ryan LE; Khawaja R; Meng S; Phay JE; Ringel MD; Sipos JA
    Thyroid; 2019 Aug; 29(8):1115-1124. PubMed ID: 31154940
    [No Abstract]   [Full Text] [Related]  

  • 3. Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules.
    San Martin VT; Lawrence L; Bena J; Madhun NZ; Berber E; Elsheikh TM; Nasr CE
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STATISTICAL COMPARISON OF AFIRMA GSC AND AFIRMA GEC OUTCOMES IN A COMMUNITY ENDOCRINE SURGICAL PRACTICE: EARLY FINDINGS.
    Harrell RM; Eyerly-Webb SA; Golding AC; Edwards CM; Bimston DN
    Endocr Pract; 2019 Feb; 25(2):161-164. PubMed ID: 30383497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules.
    Angell TE; Heller HT; Cibas ES; Barletta JA; Kim MI; Krane JF; Marqusee E
    Thyroid; 2019 May; 29(5):650-656. PubMed ID: 30803388
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing for Afirma in Thyroid Nodules with High-Risk Indeterminate Cytology (TIR3B): First Italian Experience.
    Andrioli M; Carocci S; Alessandrini S; Amini M; Van Doorne D; Pace D; Lauria A; Raffaelli M; Trimboli P
    Endocr Pathol; 2020 Mar; 31(1):46-51. PubMed ID: 31960284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National differences in cost analysis of Afirma Genomic sequencing classifier.
    Ronen O; Oichman M
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):717-724. PubMed ID: 33349964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Baca SC; Wong KS; Strickland KC; Heller HT; Kim MI; Barletta JA; Cibas ES; Krane JF; Marqusee E; Angell TE
    Cancer Cytopathol; 2017 May; 125(5):313-322. PubMed ID: 28152275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience.
    Wei S; Veloski C; Sharda P; Ehya H
    Cancer Cytopathol; 2019 Nov; 127(11):720-724. PubMed ID: 31536167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
    Nasr CE; Andrioli M; Endo M; Harrell RM; Livhits MJ; Osakwe I; Polavarapu P; Siperstein A; Wei S; Zheng X; Jiang R; Hao Y; Huang JIN; Klopper JP; Kloos RT; Kennedy G; Angell TE
    J Clin Endocrinol Metab; 2023 May; 108(6):1526-1532. PubMed ID: 36470585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules.
    Dharampal N; Smith K; Harvey A; Paschke R; Rudmik L; Chandarana S
    J Otolaryngol Head Neck Surg; 2022 Dec; 51(1):46. PubMed ID: 36544210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision-making from a fine-needle aspiration sample.
    Krane JF; Cibas ES; Endo M; Marqusee E; Hu MI; Nasr CE; Waguespack SG; Wirth LJ; Kloos RT
    Cancer Cytopathol; 2020 Jul; 128(7):452-459. PubMed ID: 32543766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel.
    Jug RC; Datto MB; Jiang XS
    Cancer Cytopathol; 2018 Jul; 126(7):471-480. PubMed ID: 29637728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy.
    Sacks WL; Bose S; Zumsteg ZS; Wong R; Shiao SL; Braunstein GD; Ho AS
    Cancer Cytopathol; 2016 Oct; 124(10):722-728. PubMed ID: 27347838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnostic gene expression thyroid testing.
    Steward DL; Kloos RT
    Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.